Vimarsana
Biggest News Aggregation in the World

Page 17 - Compugen Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compugen Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compugen Ltd Today - Breaking & Trending Today

Is Compugen Ltd. (NASDAQ: CGEN) Stock Set To Rise More? - Vimarsana News

Is Compugen Ltd. (NASDAQ: CGEN) Stock Set To Rise More?

In the last trading session, 0.42 million Compugen Ltd. (NASDAQ:CGEN) shares changed hands as the company’s beta touched 2.67. With the company’s per share price at $0.74 changed hands at -$0.01 or -1.31% during last session, the market valuation stood at $65.02M. CGEN’s last price was a disco

70,800 Shares in Compugen Ltd. (NASDAQ:CGEN) Bought by Stockman Wealth Management Inc. - Vimarsana News

70,800 Shares in Compugen Ltd. (NASDAQ:CGEN) Bought by Stockman Wealth Management Inc.

Stockman Wealth Management Inc. acquired a new stake in Compugen Ltd. (NASDAQ:CGEN – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 70,800 shares of the biotechnology company’s stock, valued at approximately $51,000. Stockman Wealth Management Inc. owned 0.08% of Compugen […]

Source: wkrb13.com
Compugen to Release First Quarter 2023 Results on Monday, May 15, 2023 - Vimarsana News

Compugen to Release First Quarter 2023 Results on Monday, May 15, 2023

HOLON, Israel, May 1, 2023 /PRNewswire/ -- Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will... | May 1, 2023

Compugen to Present Data on its Lead Pre-Clinical Asset COM503 in an Oral Presentation at the 20th CIMT Annual Meeting - Vimarsana News

Compugen to Present Data on its Lead Pre-Clinical Asset COM503 in an Oral Presentation at the 20th CIMT Annual Meeting

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE:CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

Short Interest in Compugen Ltd. (NASDAQ:CGEN) Drops By 5.5% - Vimarsana News

Short Interest in Compugen Ltd. (NASDAQ:CGEN) Drops By 5.5%

Compugen Ltd. (NASDAQ:CGEN – Get Rating) saw a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,890,000 shares, a decline of 5.5% from the March 15th total of 2,000,000 shares. Based on an average daily trading volume, of 429,600 shares, the days-to-cover ratio is […]

Source: wkrb13.com